A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting up biotech for a brighter.
Novo Nordisk said it will invest more than $2 billion in its French production site as it seeks to meet rising demand for its blockbuster obesity and diabetes treatments.
By Elena Vardon Pharmaceutical giant Novo Nordisk said it will invest more than 16 billion Danish kroner ($2.34 billion) in its French production site as it.